Catalyst Pharmaceuticals, Inc.
CPRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Catalyst Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Catalyst Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Elsbernd Brian | Chief Legal Officer | 0 | Jul 17, 2026 | 5 |
| Curran Daniel J. | Director | – | Jul 17, 2026 | 2 |
| Tierney David S | Director | 0 | Jul 17, 2026 | 4 |
| Miller Steve | Chief Op. & Scientific Officer | 0 | Jul 17, 2026 | 4 |
| Thompson Tamar | Director | 0 | Jul 17, 2026 | 3 |
| Russo Gregg | Chief HR Officer | 0 | Jul 17, 2026 | 3 |
| McEnany Patrick J | Director, Other: Chairman of Board of Directors | 0 | Jul 17, 2026 | 5 |
| Denkhaus Donald A | Director | 0 | Jul 17, 2026 | 4 |
| Del Carmen Jeffrey | Chief Commercial Officer | 0 | Jul 17, 2026 | 5 |
| Sundaram Preethi | Chief Strategy Officer | 0 | Jul 17, 2026 | 4 |
| Daly Richard J | President and CEO | 0 | Jul 17, 2026 | 4 |
| Andrews William T. | Chief Medical Officer | 0 | Jul 17, 2026 | 3 |
| Harper Molly | Director | 0 | Jul 17, 2026 | 5 |
| Kalb Michael Wayne | Chief Financial Officer | 0 | Jul 17, 2026 | 3 |
| Ingenito Gary | Chief Med. & Reg. Officer | 68,873 | May 15, 2025 | 0 |
| O'Keeffe Charles B | Director | 732,470 | Feb 19, 2025 | 0 |
| Grande Alicia | VP, Treasurer and CFO | 55,813 | Dec 29, 2023 | 0 |
| Coelho Philip H | Director | 204,887 | May 5, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Harper MollyDirector | SSaleCommon stock, par value $0.001 per share | −26.7K | $23.25 | −$621.9K | −91.9%2.36K after | 3 lots |
| Nov 28, 2025 (view filing) | Nov 26 | 2 days | Del Carmen JeffreyChief Commercial Officer | SSaleCommon Stock, par value $0.001 per share | −11.0K | $23.33 | −$256.2K | −73.5%3.96K after | |
| Nov 14, 2025 (view filing) | Nov 12 | 2 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon Stock, par value $0.001 per share | +40.0K | $22.70 | +$908.0K | +20.9%231.0K after | |
| Sep 10, 2025 (view filing) | Sep 8 | 2 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon Stock, par value $0.001 per share | −30.0K | $20.30 | −$609.0K | −10.0%271.0K after | |
| Sep 5, 2025 (view filing) | Sep 3-4 | 2 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon Stock, par value $0.001 per share | −50.0K | $19.74 | −$987.2K | −21.0%188.6K after | 2 lots |
| Aug 28, 2025 (view filing) | Aug 27 | 1 day | Tierney David SDirector | SSaleCommon Stock, par value $0.001 per share | −26.0K | $20.20 | −$525.2K | −6.4%379.6K after | |
| Aug 28, 2025 (view filing) | Aug 26 | 2 days | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −115.0K | $20.28 | −$2.33M | −10.8%949.7K after | |
| Aug 28, 2025 (view filing) | Aug 26 | 2 days | Daly Richard JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −23.0K | $20.62 | −$473.6K | −9.2%226.8K after | |
| Jun 12, 2025 (view filing) | Jun 10-11 | 2 days | Sundaram PreethiChief Strategy Officer | SSaleCommon Stock, par value $0.001 per share | −3.92K | $26.41 | −$103.6K | −8.7%41.1K after | 2 lots |
| Jun 10, 2025 (view filing) | Jun 6-9 | 4 days | McEnany Patrick JDirector, Other: Chairman of Board of Directors | SSaleCommon Stock, par value $0.001 per share | −200.0K | $26.09 | −$5.22M | −4.5%4.28M after | 2 lots |
| Jun 3, 2025 (view filing) | May 30 | 4 days | Daly Richard JPresident and CEO | SSaleCommon stock, par value $0.001 per share | +70.0K | $24.86 | +$1.74M | +53.9%199.8K after | |
| May 15, 2025 (view filing) | May 13-14 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −244.0K | $23.67 | −$5.78M | −78.0%68.9K after | 2 lots |
| Mar 7, 2025 (view filing) | Mar 5-6 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −225.0K | $21.75 | −$4.89M | −76.6%68.9K after | 2 lots |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon Stock, par value $0.001 per share | −63.0K | $22.98 | −$1.45M | −25.0%188.6K after | 2 lots |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Del Carmen JeffreyChief Commercial Officer | SSaleCommon stock, par value $0.001 per share | −30.4K | $22.89 | −$696.4K | −100.0%0 after | |
| Dec 11, 2024 (view filing) | Dec 10 | 1 day | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −50.0K | $21.93 | −$1.10M | −6.8%687.0K after | |
| Nov 29, 2024 (view filing) | Nov 27 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −12.0K | $22.72 | −$272.6K | −18.9%51.4K after | 2 lots |
| Nov 29, 2024 (view filing) | Nov 27 | 2 days | Harper MollyDirector | SSaleCommon stock, par value $0.001 per share | −17.5K | $22.00 | −$385.0K | −100.0%0 after | |
| Nov 29, 2024 (view filing) | Nov 26 | 3 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon Stock, par value $0.001 per share | −13.3K | $21.63 | −$286.7K | −7.2%171.2K after | 2 lots |
| Nov 22, 2024 (view filing) | Nov 20 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −38.0K | $21.20 | −$805.6K | −42.5%51.4K after | |
| Nov 21, 2024 (view filing) | Nov 19-20 | 2 days | McEnany Patrick JDirector, Other: Chairman of Board of Directors | SSaleCommon stock, par value $0.001 per share | −170.8K | $21.23 | −$3.63M | −3.7%4.48M after | 2 lots |
| Nov 15, 2024 (view filing) | Nov 13-14 | 2 days | McEnany Patrick JDirector, Other: Chairman of Board of Directors | SSaleCommon stock, par value $0.001 per share | −137.2K | $22.58 | −$3.10M | −3.0%4.48M after | 2 lots |
| Nov 13, 2024 (view filing) | Nov 11-12 | 2 days | McEnany Patrick JDirector, Other: Chairman of Board of Directors | SSaleCommon stock, par value $0.001 per share | −492.0K | $23.39 | −$11.5M | −9.9%4.48M after | 3 lots |
| Aug 23, 2024 (view filing) | Aug 21 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −15.0K | $20.10 | −$301.5K | −4.1%348.9K after | |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −150.0K | $20.35 | −$3.05M | −18.2%675.1K after | 3 lots |
| Aug 13, 2024 (view filing) | Aug 9 | 4 days | Del Carmen JeffreyChief Commercial Officer | SSaleCommon stock, par value $0.001 per share | −36.1K | $18.42 | −$664.3K | −74.5%12.4K after | 2 lots |
| Aug 13, 2024 (view filing) | Aug 9 | 4 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −100.0K | $18.04 | −$1.80M | −66.1%51.4K after | |
| Jun 11, 2024 (view filing) | Jun 7 | 4 days | Del Carmen JeffreyChief Commercial Officer | SSaleCommon stock, par value $0.001 per share | −7.54K | $16.07 | −$121.2K | −29.0%18.4K after | |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −80.0K | $16.16 | −$1.29M | −60.9%51.4K after | |
| Jun 5, 2024 (view filing) | Jun 4 | 1 day | Daly Richard JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −17.3K | $15.98 | −$276.8K | −6.9%234.8K after | |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Harper MollyDirector | SSaleCommon Stock, par value $0.001 per share | −5.33K | $16.30 | −$86.9K | −100.0%0 after | |
| Apr 10, 2024 (view filing) | Apr 8 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −25.0K | $15.68 | −$392.0K | −6.7%348.9K after | |
| Mar 28, 2024 (view filing) | Mar 27 | 1 day | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon stock, par value $0.001 per share | −25.0K | $16.44 | −$411.0K | −16.7%124.4K after | |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Harper MollyDirector | SSaleCommon stock, par value $0.001 per share | −14.0K | $14.39 | −$201.4K | −100.0%0 after | 2 lots |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −50.0K | $13.33 | −$666.5K | −13.0%333.5K after | |
| Dec 12, 2023 (view filing) | Dec 8-11 | 4 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −100.0K | $13.97 | −$1.40M | −66.4%50.6K after | 4 lots |
| Dec 8, 2023 (view filing) | Dec 6 | 2 days | Ingenito GaryChief Med. & Reg. Officer | SSaleCommon stock, par value $0.001 per share | −50.0K | $14.02 | −$701.0K | −56.6%38.4K after | |
| Dec 7, 2023 (view filing) | Dec 5 | 2 days | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −40.0K | $14.24 | −$569.6K | −5.8%647.5K after | |
| May 17, 2023 (view filing) | May 15 | 2 days | McEnany Patrick JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −26.2K | $13.23 | −$346.0K | −0.7%3.95M after | |
| Apr 7, 2023 (view filing) | Apr 5 | 2 days | Tierney David SDirector | SSaleCommon stock, par value $0.001 per share | −30.0K | $16.83 | −$504.9K | −8.7%313.5K after | |
| Mar 30, 2023 (view filing) | Mar 29 | 1 day | Del Carmen JeffreyChief Commercial Officer | SSaleCommon stock, par value $0.001 per share | −40.0K | $16.70 | −$667.8K | −84.1%7.54K after | 2 lots |
| Mar 30, 2023 (view filing) | Mar 28-29 | 2 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon stock, par value $0.001 per share | −108.2K | $16.61 | −$1.80M | −68.2%50.6K after | 7 lots |
| Mar 24, 2023 (view filing) | Mar 22 | 2 days | Grande AliciaVP, Treasurer and CFO | SSaleCommon stock, par value $0.001 per share | −41.8K | $16.50 | −$689.5K | −45.2%50.6K after | 2 lots |
| Mar 22, 2023 (view filing) | Mar 20 | 2 days | Elsbernd BrianChief Compliance/Legal Officer | SSaleCommon Stock, par value $0.001 per share | −50.0K | $16.07 | −$803.5K | −26.6%138.1K after | |
| Dec 8, 2022 (view filing) | Dec 6 | 2 days | Ingenito GaryChief Medical Officer | SSaleCommon stock, par value $0.001 per share | −5.92K | $16.85 | −$99.7K | −16.1%30.8K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Grande AliciaVP, Treasurer and CFO | SSaleCommon Stock, par value $0.001 per share | −120.0K | $16.53 | −$1.98M | −81.4%27.4K after | |
| Nov 23, 2022 (view filing) | Nov 21-23 | 2 days | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −100.0K | $15.69 | −$1.57M | −15.3%553.8K after | 2 lots |
| Nov 23, 2022 (view filing) | Nov 21-23 | 2 days | Coelho Philip HDirector | SSaleCommon stock, par value $0.001 per share | −100.0K | $15.87 | −$1.59M | −40.1%149.6K after | 3 lots |
| Nov 22, 2022 (view filing) | Nov 18-21 | 4 days | McEnany Patrick JPresident and CEO | SSaleCommon stock, par value $0.001 per share | −500.0K | $15.53 | −$7.77M | −11.4%3.90M after | 2 lots |
| Nov 17, 2022 (view filing) | Nov 15 | 2 days | O'Keeffe Charles BDirector | SSaleCommon stock, par value $0.001 per share | +88.0K | $16.04 | +$1.41M | +18.4%565.1K after |